Insights - Orexigen Therapeutics (OREX) ripped higher on Tuesday with news that a new – and profoundly important – patent has been issued for Contrave, Orexigen’s approved weight … Continue Reading
Read nowInsights - The private pharmaceutical company Eddingpharm will pay Amarin Corp (AMRN) $15 million for rights to develop and commercialize Amarin’s prescription-grade fish oil pill, Vascepa, in China, Hong … Continue Reading
Read nowInsights - Xencor, Inc (XNCR) priced an equity financing on Wednesday morning, selling 7.5 million shares of common stock at $14.25 for gross proceeds of $106 million. … Continue Reading
Read nowInsights - Healthcare investors will be well-aware of Valeant's (VRX) $10 billion acquisition of Salix Pharmaceuticals (SLXP), announced over the weekend, but Monday morning has already been crammed full of biotech dealflow. Here's a quick recap.
Read nowInsights - In healthcare and pharmaceutical news this week, famed predictor of the subprime mortgage crisis and hedge fund manager Kyle Bass has taken aim at the … Continue Reading
Read nowInsights - Genzyme (of Sanofi [SNY]) announced on Wednesday a collaboration with the private gene therapy company Voyager Therapeutics.
Read nowInsights - Pfizer (PFE) announced plans to buy injectable generics & biosimialar developer Hospira (HSP) at $90/share, for an enterprise value of $17 billion. Hospira closed Wednesday at $64.80.
Read now
